Considerations for Child Cancer Survivors and Immunocompromised Children to Prevent Secondary HPV-associated Cancers
| dc.contributor.author | Imburgia, Teresa M. | |
| dc.contributor.author | Shew, Marcia L. | |
| dc.contributor.author | Gravitt, Patti E. | |
| dc.contributor.author | Katzenellenbogen, Rachel A. | |
| dc.contributor.department | Pediatrics, School of Medicine | en_US |
| dc.date.accessioned | 2020-10-30T19:56:46Z | |
| dc.date.available | 2020-10-30T19:56:46Z | |
| dc.date.issued | 2020-09 | |
| dc.description.abstract | Survivors of childhood cancer and other immunocompromised children are at high risk for the development of secondary Human Papillomavirus (HPV)-associated cancers. In this overview, the authors examine the epidemiology of vaccine efficacy, the natural history of HPV infections, and accelerated HPV-associated cancer development in these populations. The authors highlight the opportunities for preventive care and future research directives. | en_US |
| dc.eprint.version | Author's manuscript | en_US |
| dc.identifier.citation | Imburgia, T. M., Shew, M. L., Gravitt, P. E., & Katzenellenbogen, R. A. (2020). Considerations for Child Cancer Survivors and Immunocompromised Children to Prevent Secondary HPV-associated Cancers. Transplantation. https://doi.org/10.1097/tp.0000000000003444 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/24216 | |
| dc.language.iso | en | en_US |
| dc.publisher | Wolters Kluwer | en_US |
| dc.relation.isversionof | 10.1097/tp.0000000000003444 | en_US |
| dc.relation.journal | Transplantation | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.source | Author | en_US |
| dc.subject | HPV vaccine | en_US |
| dc.subject | immunocompromised children | en_US |
| dc.subject | childhood cancer | en_US |
| dc.title | Considerations for Child Cancer Survivors and Immunocompromised Children to Prevent Secondary HPV-associated Cancers | en_US |
| dc.type | Article | en_US |